Disposition of 183 shares by Michael Hilton of Accolade subject to Rule 16b-3

ACCD Stock  USD 3.86  0.11  2.93%   
About 58% of all Accolade's shareholders are looking to take a long position. The analysis of the overall investor sentiment regarding Accolade suggests that some traders are interested. The current market sentiment, together with Accolade's historical and current headlines, can help investors time the market. In addition, many technical investors use Accolade stock news signals to limit their universe of possible portfolio assets.
  
Filed transaction by Accolade Director. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)

Read at thelincolnianonline.com
news
  
Accolade insider trading alert for disposition of restricted stock units by Michael Hilton, Director, on 10th of October 2024. This event was filed by Accolade with SEC on 2024-10-10. Statement of changes in beneficial ownership - SEC Form 4

Accolade Investor Sentiment by Other News Outlets

Investor sentiment, mood or attitude towards Accolade can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

Accolade Fundamental Analysis

We analyze Accolade's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Accolade using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Accolade based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Book Value Per Share

Book Value Per Share Comparative Analysis

Accolade is currently under evaluation in book value per share category among its peers. Book Value per Share (B/S) can be calculated by subtracting liabilities from assets, and then dividing it by the total number of currently outstanding shares. It indicates the level of safety associated with each common share after removing the effects of liabilities. In other words, a shareholder can use this ratio to see how much he or she can sell the stake in the company in the event of a liquidation.

Accolade Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Accolade stock to make a market-neutral strategy. Peer analysis of Accolade could also be used in its relative valuation, which is a method of valuing Accolade by comparing valuation metrics with similar companies.

Peers

Accolade Related Equities

CMAXCareMax   9.52   
0%
100.0%
PHRPhreesia   3.60   
0%
37.0%
HCATHealth Catalyst   2.08   
0%
21.0%
DHDefinitive Healthcare   1.50   
0%
15.0%
NRCNational Research   0.92   
0%
9.0%
PINCPremier   0.70   
0%
7.0%
HSTMHealthStream   0.21   
0%
2.0%
EVHEvolent Health   0.08   
1.0%
0%
CERTCertara   0.53   
5.0%
0%
PRVAPrivia Health   0.83   
8.0%
0%

Complementary Tools for Accolade Stock analysis

When running Accolade's price analysis, check to measure Accolade's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Accolade is operating at the current time. Most of Accolade's value examination focuses on studying past and present price action to predict the probability of Accolade's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Accolade's price. Additionally, you may evaluate how the addition of Accolade to your portfolios can decrease your overall portfolio volatility.
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years